Close Menu

SiMoA

Cambridge, Mass.-based Quanterix will use the funds to develop its AccuPSA prostate cancer test, which runs on its single molecule array, or SiMoA, platform.

The results offer the prospect for improved detection and measurement of low-concentration proteins – a development that has potentially broad applications in protein biomarker research, diagnostics, and drug development, David Duffy, senior director of platform research at Quanterix, told ProteoMonitor.

Pages

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.